MONDAY.COM LTD (MNDY)

IL0011762130 - Common Stock

288.695  +12.44 (+4.5%)

Fundamental Rating

5

MNDY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. While MNDY has a great health rating, there are worries on its profitability. MNDY shows excellent growth, but is valued quite expensive already.



3

1. Profitability

1.1 Basic Checks

MNDY had positive earnings in the past year.
In the past year MNDY had a positive cash flow from operations.
MNDY had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MNDY reported negative operating cash flow in multiple years.

1.2 Ratios

With a decent Return On Assets value of 1.37%, MNDY is doing good in the industry, outperforming 65.95% of the companies in the same industry.
Looking at the Return On Equity, with a value of 2.23%, MNDY is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROIC N/A
ROA(3y)-9.35%
ROA(5y)-38.64%
ROE(3y)-13.31%
ROE(5y)-243.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 2.39%, MNDY is in the better half of the industry, outperforming 67.03% of the companies in the same industry.
MNDY's Gross Margin of 89.46% is amongst the best of the industry. MNDY outperforms 96.77% of its industry peers.
In the last couple of years the Gross Margin of MNDY has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 89.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.12%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MNDY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MNDY has more shares outstanding
MNDY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MNDY has an Altman-Z score of 14.17. This indicates that MNDY is financially healthy and has little risk of bankruptcy at the moment.
MNDY's Altman-Z score of 14.17 is amongst the best of the industry. MNDY outperforms 89.25% of its industry peers.
There is no outstanding debt for MNDY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.17
ROIC/WACCN/A
WACC9.57%

2.3 Liquidity

A Current Ratio of 2.67 indicates that MNDY has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.67, MNDY is doing good in the industry, outperforming 71.33% of the companies in the same industry.
MNDY has a Quick Ratio of 2.67. This indicates that MNDY is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.67, MNDY is doing good in the industry, outperforming 72.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.12% over the past year.
MNDY shows a strong growth in Revenue. In the last year, the Revenue has grown by 33.90%.
Measured over the past years, MNDY shows a very strong growth in Revenue. The Revenue has been growing by 65.46% on average per year.
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.81%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5YN/A
Sales Q2Q%32.67%

3.2 Future

MNDY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.92% yearly.
Based on estimates for the next years, MNDY will show a very strong growth in Revenue. The Revenue will grow by 26.77% on average per year.
EPS Next Y57.92%
EPS Next 2Y36.89%
EPS Next 3Y34.67%
EPS Next 5Y33.92%
Revenue Next Year32.43%
Revenue Next 2Y29.8%
Revenue Next 3Y28.77%
Revenue Next 5Y26.77%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 94.65, which means the current valuation is very expensive for MNDY.
MNDY's Price/Earnings ratio is in line with the industry average.
MNDY is valuated expensively when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 83.73, which means the current valuation is very expensive for MNDY.
MNDY's Price/Forward Earnings ratio is in line with the industry average.
MNDY is valuated expensively when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 94.65
Fwd PE 83.73

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MNDY is valued a bit cheaper than 64.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.75
EV/EBITDA N/A

4.3 Compensation for Growth

MNDY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as MNDY's earnings are expected to grow with 34.67% in the coming years.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y36.89%
EPS Next 3Y34.67%

0

5. Dividend

5.1 Amount

MNDY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONDAY.COM LTD

NASDAQ:MNDY (11/22/2024, 11:42:31 AM)

288.695

+12.44 (+4.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.41B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 94.65
Fwd PE 83.73
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 2.39%
GM 89.46%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y57.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y